RSS

Competitions and Markets Authority (CMA)

Two pharmaceutical companies have been accused of breaching competition law in relation to the antibiotic Nitrofurantoin by the Competition and Markets Authority (CMA). Read more

News

The CMA has provisionally found that 4 pharmaceutical companies broke the law by agreeing not to compete in the supply of an anti-nausea drug in the UK. Read more

News

The Competition and Markets Authority (CMA) has released a statement alleging that drug company, Concordia, has abused its position with the NHS to overcharge for liothyronine tablets — an essential thyroid drug. Read more

News

The UK’s Competition and Markets Authority (CMA) dishes the two firms a record fine of nearly £90 million for charging excessive prices to the NHS for an anti-epilepsy drug. Read more

News

China plans to launch a large-scale and systematic investigation into drug firms, both foreign and local, reported state newspaper China Daily Read more

News

GlaxoSmithKline (GSK), Generics UK (GUK) and Alpharma have been fined £45m by the Competition and Markets Authority (CMA) for anti-competitive conduct and agreements Read more

News

Pfizer and Flynn Pharma stand accused of overcharging the NHS millions for an anti-epilepsy drug. Read more

News